Evidence map›Paper›PMID 34778019›Full record

ArticlePublic health action2021

Low yield but high levels of multidrug resistance in urinary tract infections in a tertiary hospital, Nepal.

R Baral, L B Shrestha, N Ortuño-Gutiérrez, P Pyakure, B Rai, S P Rimal, S Singh, S K Sharma, B Khanal, K Selvaraj and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Public health action, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Unraveling Biofilm-Forming Uropathogens: Isolation and Antimicrobial Resistance Patterns at Nepal Police Hospital, Kathmandu.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Role of Biofilm in Bacterial Infection and Antimicrobial Resistance.JNMA; journal of the Nepal Medical Association · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

R BaralBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
L B ShresthaBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
N Ortuño-GutiérrezDamien Foundation Belgium, Brussels, Belgium.
P PyakureBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
B RaiBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
S P RimalBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
S SinghBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
S K SharmaBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
B KhanalBP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
K SelvarajAll India Institute of Medical Sciences, Nagpur, India.
A M V KumarInternational Union Against Tuberculosis and Lung Disease (The Union), Paris, France.
B.P. Koirala Institute of Health Sciences · NPAll India Institute of Medical Sciences, NagpurInternational Union Against Tuberculosis and Lung Disease · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

settingThere are concerns about the occurrence of multidrug resistance (MDR) in patients with urine tract infections (UTI) in Nepal.

objectiveTo determine culture positivity, trends in MDR among

designThis was a cross-sectional study using secondary laboratory data.

resultsAmong 116,417 urine samples tested, 19,671 (16.9%) were culture-positive, with an increasing trend in the number of samples tested and culture positivity.

conclusionLow culture positivity is worrying and requires further work into improving diagnostic protocols. Decreasing trends in MDR are a welcome sign. Information on seasonal changes that peak in July-August can help laboratories better prepare for this time with adequate buffer stocks to ensure culture and antibiotic susceptibility testing.

Indexed as

antimicrobial resistanceseasonalityuropathogensUTI

Identifiers

PMID34778019
PMCPMC8575377
OpenAlexW3211729759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.